Unique ID issued by UMIN | UMIN000014433 |
---|---|
Receipt number | R000016792 |
Scientific Title | Phase I/II study of Ibuprofen gargle for chemotherapy or chemo-radiation therapy induced mucositis oral |
Date of disclosure of the study information | 2014/07/01 |
Last modified on | 2019/01/02 15:27:07 |
Phase I/II study of Ibuprofen gargle for chemotherapy or chemo-radiation therapy induced mucositis oral
Phase I/II study of Ibuprofen gargle for mucositis oral
Phase I/II study of Ibuprofen gargle for chemotherapy or chemo-radiation therapy induced mucositis oral
Phase I/II study of Ibuprofen gargle for mucositis oral
Japan |
Malignancy
Medicine in general | Hematology and clinical oncology | Oto-rhino-laryngology |
Radiology | Adult |
Malignancy
NO
To characterize the safety of ibuprofen gargle.
To assess the effect of ibuprofen gargle treatment.
Safety,Efficacy
Exploratory
Phase I,II
Safety: Adverse events and serious adverse drug reactions, abnormal changes in hematology and chemistry lab values, specifically those associated with hepatic and renal function; and assessment of physical examinations, vital signs
1.pain score
2.Improvement level of feeding, taking medicine, drinking water, conversation, and sleep
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
ibuprofen gargle
20 | years-old | <= |
Not applicable |
Male and Female
1.Patients with age: <= 20 years
2.Patient will provide written informed consent and authorization to release personal health information.
3.Inpatients.
1.No known CNS metastasis.
2.Impairment of GI function or GI disease
3.Other concurrent severe and/or uncontrolled concomitant medical conditions
4.Impaired cardiac function or clinically significant heart disease, including any one of the following:
_Angina pectoris within 3 months
_Acute myocardial infarction within 3 months
_Other clinically significant heart disease
5.No exist the aspirin-induced asthma.
6.No known hypersensitivity to any component of study regimen.
7.No use of zidovudine
8.Drug dependence disease and alcoholism
9.Patients unwilling or unable to comply with the protocol
10.No use of aspirin
11.Under the pregnancy or the nursing
12.Women of child-bearing potential who are pregnant.
13.No participate in other clinical trials.
14.Without participating in a similar examination clinical trial
15.Patients judged inappropriate for this study by physicians.
20
1st name | |
Middle name | |
Last name | Midori Hirai |
Kobe University Hospital
Department of Hospital Pharmacy
7-5-2 kusunoki-cho Chuo-ku Kobe Hyogo 650-0017 JAPAN
078-382-6669
ioroit@med.kobe-u.ac.jp
1st name | |
Middle name | |
Last name | Takeshi Ioroi |
Kobe University Hospital
Department of Hospital Pharmacy
7-5-2, Kusunoki-cho, Chuo-ku, Kobe
078-382-6669
chiken@med.kobe-u.ac.jp
Kobe University Hospital
Kobe University Hospital
Other
NO
2014 | Year | 07 | Month | 01 | Day |
Published
Completed
2014 | Year | 07 | Month | 01 | Day |
2014 | Year | 08 | Month | 01 | Day |
2016 | Year | 01 | Month | 31 | Day |
2016 | Year | 04 | Month | 30 | Day |
2016 | Year | 07 | Month | 01 | Day |
2016 | Year | 08 | Month | 01 | Day |
2014 | Year | 06 | Month | 30 | Day |
2019 | Year | 01 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016792
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |